NeoGenomics, Inc. (NEO)

NASDAQ: NEO · Real-Time Price · USD

10.26

-1.18 (-10.31%)

At close: Feb 18, 2026, 4:00 PM EST

10.12

-0.14 (-1.37%)

After-hours: Feb 18, 2026, 7:52 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Clinical Services and Advanced Diagnostics	727.33M	660.57M	591.64M	509.73M	-
Clinical Services and Advanced Diagnostics Growth	10.11%	11.65%	16.07%	-	-
Clinical Services	-	-	-	-	404.17M
Clinical Services Growth	-	-	-	-	5.71%
Advanced Diagnostics	-	-	-	-	80.16M
Advanced Diagnostics Growth	-	-	-	-	29.05%
Total	727.33M	660.57M	591.64M	509.73M	484.33M
Total Growth	10.11%	11.65%	16.07%	5.24%	8.97%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	727.33M	660.57M	591.64M	509.73M	484.33M
United States Growth	10.11%	11.65%	16.07%	5.24%	8.97%
Total	727.33M	660.57M	591.64M	509.73M	484.33M
Total Growth	10.11%	11.65%	16.07%	5.24%	8.97%

Source: S&P Global Market Intelligence.